By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Quark Biotech, Inc. 

10265 Carnegie Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-791-6114 Fax: 216-791-6115




Company News
Quark Biotech, Inc. Files with SEC for $86.3 Million IPO 3/30/2007 10:11:36 AM
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Pays $515 Million For AnorMED (AOM.TO) 9/26/2006 6:08:10 PM
Pfizer Inc. (PFE) Expands Research Commitment To Ophthalmology Through Licensing Agreement With Quark Biotech, Inc.; Atugen AG Will Receive Payments Up To US$95 Million 9/26/2006 12:06:22 PM
Alnylam Pharmaceuticals (ALNY) Grants Quark Biotech, Inc. A License To Develop And Commercialize Two RNAi Therapeutic Products 9/26/2006 11:47:58 AM
Quark Biotech, Inc. Awarded Certification For Agilent Technologies Inc.'s (A) Certified Microarray Service Provider Program10/19/2005 5:13:02 PM
Quark Biotech, Inc. Discovers Role Of RTP801 In The Development Of Age-related Macular Degeneration10/19/2005 5:12:59 PM
Quark Biotech, Inc. Receives Notice Of Allowance For U.S. Patent On p53 Inhibitor10/19/2005 5:12:54 PM
Quark Biotech, Inc. Discovers Role Of Ero-1L Alpha Gene In Cancer: Involvement In Protein Secretion Under Hypoxic Conditions10/19/2005 5:12:51 PM
Sanwa Kagaku Kenkyusho And Quark Biotech, Inc. Enter Collaboration To License Dyslipidemia Therapy10/19/2005 5:12:39 PM
Quark Biotech, Inc. Announces Discovery Of Novel Target For Treatment Of Ischemia-induced Retinopathy10/19/2005 5:12:18 PM